Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis

<div>The cumulative survival rates in subgroups of nonviral cirrhosis patients. (a) The cumulative survival rates in all subgroups of nonviral cirrhosis patients. (b) The cumulative survival rates in the cryptogenic group and the alcohol group. (c) The cumulative survival rates in the cryptogenic group and the autoimmune group. (d) The cumulative survival rates in the alcohol group and the autoimmune group.</div>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis 

Figure 3 | Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis 